Cointime

Truveris

company

About

Truveris is a technology company driving transparency, access and lower costs across the prescription drug ecosystem.

  • 101 - 250

Highlights

Total Funding Amount
$3.80M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Series A
Last Funding Money Raised
$3.80M
Industries
Health Care,Information Technology,SaaS,Wellness
Founded date
Jan 1, 2009
Number Of Employee
101 - 250
Operating Status
Active

Truveris brings transparency to the prescription drug ecosystem through data-driven innovations. Truveris’ platform offers customers – from the individual patient to employers, retailers, pharmacy benefits stakeholders, and manufacturers – the data and insights they need to effectively and efficiently manage rising costs and market access challenges.


Based in Manhattan, Truveris is backed by Canaan Partners, New Leaf Venture Partners, Tribeca Venture Partners, New Atlantic Ventures and First Round Capital.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$3.80M
Truveris has raised a total of $3.80M in funding over 2 rounds. Their latest funding was raised on Feb 1, 2011 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Feb 1, 2011 Series A $3.80M 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
1
Truveris is funded by 1 investors. GSA Venture Partners are the most recent investors.
Investor Name Lead Investor Funding Round
GSA Venture Partners — Series A
Cointime
İçerikler
Şirket.